MedPath

ASTRAZENECA SINGAPORE PTE LTD

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:1
Completed:4

Trial Phases

2 Phases

Phase 3:2
Phase 4:2

Drug Approvals

73

HSA:73

Drug Approvals

DATROWAY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL

Approval Date
May 10, 2025
HSA

VOYDEYA FILM-COATED TABLET 100 MG + 50 MG

Approval Date
Dec 26, 2024
HSA

VOYDEYA FILM-COATED TABLET 100 MG + 100 MG

Approval Date
Dec 26, 2024
HSA

STRENSIQ SOLUTION FOR INJECTION 100 MG/ML

Approval Date
Oct 29, 2024
HSA

STRENSIQ SOLUTION FOR INJECTION 40 MG/ML

Approval Date
Oct 29, 2024
HSA

TRUQAP FILM-COATED TABLETS 200MG

Approval Date
Oct 14, 2024
HSA

TRUQAP FILM-COATED TABLETS 160MG

Approval Date
Oct 14, 2024
HSA

EDISTRIDE FILM-COATED TABLET 10MG

Approval Date
Jul 22, 2024
HSA

ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML

Approval Date
Jun 19, 2024
HSA

SIDAPVIA FIXED DOSE COMBINATION TABLET 10 MG/100 MG

Approval Date
Feb 20, 2024
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (50.0%)
Phase 4
2 (50.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.